Pathological and non-pathological systems featuring mitochondrial transfer
| Condition . | . | Result . | Reference . |
|---|---|---|---|
| Pathological | Lung carcinoma | Rescued mitochondrial function | Spees et al., 2006 |
| Osteosarcoma | Rescued mitochondrial function | Cho et al., 2012 | |
| Acute lung injury | Cellular protection and tissue repair | Islam et al., 2012 | |
| Ischemia | Preserving myocardial energetics, cell viability, and enhanced post-infarct cardiac function—protect the heart from ischemia-reperfusion injury | Masuzawa et al., 2013 | |
| Allergic airway inflammation | Enhanced rescue of epithelial injury | Ahmad et al., 2014 | |
| Chronic obstructive pulmonary disease | Attenuation of cigarette smoke–induced lung damage | Li et al., 2014 | |
| Ischemia | Cardioprotection from ischemia-reperfusion injury | Cowan et al., 2016 | |
| Cerebral ischemia | Amplified cell survival signals—neurorecovery | Hayakawa et al., 2016 | |
| Acute respiratory distress syndrome | Enhancement of phagocytic activity of lung alveolar macrophages | Jackson et al., 2016a; Jackson et al., 2016b | |
| Acute myeloid leukemia | Resistance to chemotherapy | Moschoi et al., 2016 | |
| Canine transmissible venereal tumor | Acquisition of functional mtDNA | Strakova et al., 2016, 2020 | |
| Bladder cancer | Increased invasiveness | Lu et al., 20178 | |
| Acute respiratory distress syndrome | Anti-inflammatory and highly phagocytic macrophage phenotype resulting in amelioration of lung injury | Morrison et al., 2017 | |
| PD | Acquisition of functional mitochondria | Rostami et al., 2017 | |
| Oxygen-glucose deprivation | Restoring brain endothelial energetics and barrier integrity | Hayakawa et al., 2018 | |
| Hypoxia/reoxygenation injury | Attenuation of CM apoptosis | Shen et al., 2018 | |
| Asthma | Alleviated asthmatic inflammation | Yao et al., 2018 | |
| Diabetic nephropathy | Structural and functional restoration of renal proximal tubular epithelial cells | Konari et al., 2019 | |
| MM | Enhanced mitochondrial metabolism, protumoral effect | Marlein et al., 2019 | |
| Neonatal cardiomyopathy | Improvement of CM bioenergetics and viability in male rats exposed to pre-gestational diabetes | Louwagie et al., 2021 | |
| Lung carcinoma | Enhancement of metastatic potential during tumor progression | Takenaga et al., 2021 | |
| Cerebral ischemia | Increased neuronal survival and improved metabolism | Tseng et al., 2021 | |
| Glioblastoma | Adaptation of non-tumor astrocytes to tumor-like metabolism and hypoxia conditions | Valdebenito et al., 2021 | |
| AD | Increased transmitophagy of defective neuronal mitochondrial, potential alleviation of AD pathology and symptoms | Lampinen et al., 2022 | |
| Non-pathological | Cardiac homeostasis | Preserved metabolic stability and organ function | Nicolas-Avila et al., 2020 |
| White adipose tissue homeostasis | Metabolic homeostasis, impairment leads to obesity | Brestoff et al., 2021 | |
| Metabolic preconditioning of the heart | Cardio-protection against lipotoxic or ischemic stresses elicited by obesity | Crewe et al., 2021 | |
| Wound healing | Promotion of pro-angiogenic activity of MSCs via their metabolic remodeling | Levoux et al., 2021 |
| Condition . | . | Result . | Reference . |
|---|---|---|---|
| Pathological | Lung carcinoma | Rescued mitochondrial function | Spees et al., 2006 |
| Osteosarcoma | Rescued mitochondrial function | Cho et al., 2012 | |
| Acute lung injury | Cellular protection and tissue repair | Islam et al., 2012 | |
| Ischemia | Preserving myocardial energetics, cell viability, and enhanced post-infarct cardiac function—protect the heart from ischemia-reperfusion injury | Masuzawa et al., 2013 | |
| Allergic airway inflammation | Enhanced rescue of epithelial injury | Ahmad et al., 2014 | |
| Chronic obstructive pulmonary disease | Attenuation of cigarette smoke–induced lung damage | Li et al., 2014 | |
| Ischemia | Cardioprotection from ischemia-reperfusion injury | Cowan et al., 2016 | |
| Cerebral ischemia | Amplified cell survival signals—neurorecovery | Hayakawa et al., 2016 | |
| Acute respiratory distress syndrome | Enhancement of phagocytic activity of lung alveolar macrophages | Jackson et al., 2016a; Jackson et al., 2016b | |
| Acute myeloid leukemia | Resistance to chemotherapy | Moschoi et al., 2016 | |
| Canine transmissible venereal tumor | Acquisition of functional mtDNA | Strakova et al., 2016, 2020 | |
| Bladder cancer | Increased invasiveness | Lu et al., 20178 | |
| Acute respiratory distress syndrome | Anti-inflammatory and highly phagocytic macrophage phenotype resulting in amelioration of lung injury | Morrison et al., 2017 | |
| PD | Acquisition of functional mitochondria | Rostami et al., 2017 | |
| Oxygen-glucose deprivation | Restoring brain endothelial energetics and barrier integrity | Hayakawa et al., 2018 | |
| Hypoxia/reoxygenation injury | Attenuation of CM apoptosis | Shen et al., 2018 | |
| Asthma | Alleviated asthmatic inflammation | Yao et al., 2018 | |
| Diabetic nephropathy | Structural and functional restoration of renal proximal tubular epithelial cells | Konari et al., 2019 | |
| MM | Enhanced mitochondrial metabolism, protumoral effect | Marlein et al., 2019 | |
| Neonatal cardiomyopathy | Improvement of CM bioenergetics and viability in male rats exposed to pre-gestational diabetes | Louwagie et al., 2021 | |
| Lung carcinoma | Enhancement of metastatic potential during tumor progression | Takenaga et al., 2021 | |
| Cerebral ischemia | Increased neuronal survival and improved metabolism | Tseng et al., 2021 | |
| Glioblastoma | Adaptation of non-tumor astrocytes to tumor-like metabolism and hypoxia conditions | Valdebenito et al., 2021 | |
| AD | Increased transmitophagy of defective neuronal mitochondrial, potential alleviation of AD pathology and symptoms | Lampinen et al., 2022 | |
| Non-pathological | Cardiac homeostasis | Preserved metabolic stability and organ function | Nicolas-Avila et al., 2020 |
| White adipose tissue homeostasis | Metabolic homeostasis, impairment leads to obesity | Brestoff et al., 2021 | |
| Metabolic preconditioning of the heart | Cardio-protection against lipotoxic or ischemic stresses elicited by obesity | Crewe et al., 2021 | |
| Wound healing | Promotion of pro-angiogenic activity of MSCs via their metabolic remodeling | Levoux et al., 2021 |